Becton Dickinson & Co(BDX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 53.21 | EPS (ttm) | 3.32 | Insider Own | 0.22% | Shs Outstand | 272.4M | Perf Week | -5.92% |
| Market Cap | 48.05B | Forward P/E | 13.27 | EPS next Y | 4.91% | Insider Trans | -1.98% | Shs Float | 271.8M | Perf Month | -2.75% |
| Enterprise Value | 64.00B | PEG | 1.7 | EPS next Q | 4.07 | Inst Own | 99.86% | Short Float | 3.45% | Perf Quarter | 19.37% |
| Income | 0.94B | P/S | 2.31 | EPS this Y | 11.97% | Inst Trans | -1.44% | Short Ratio | 4.47 | Perf Half Y | 8.12% |
| Sales | 20.84B | P/B | 1.97 | EPS next 5Y | 7.8% | ROA | 2.44% | Short Interest | 9.37M | Perf YTD | 15.68% |
| Book/sh | 89.64 | P/C | 55.62 | EPS past 3/5Y | -0.35% 16.45% | ROE | 5.17% | 52W High | -8.62% ($193.07) | Perf Year | 19.14% |
| Cash/sh | 3.17 | P/FCF | 18.97 | Sales past 3/5Y | 4.99% 6.32% | ROIC | 2.48% | 52W Low | 38.33% ($127.54) | Perf 3Y | -15.84% |
| Dividend Est. | $3.99 (2.26%) | EV/EBITDA | 12.18 | EPS Y/Y TTM | -40.38% | Gross Margin | 46.44% | Volatility(W/M) | 2.34% 2.17% | Perf 5Y | -10.86% |
| Dividend TTM | 3.98 | EV/Sales | 3.07 | Sales Y/Y TTM | -2.56% | Oper. Margin | 14.54% | ATR (14) | 4.35 | Perf 10Y | 34.66% |
| Dividend Ex-Date | 2026/9/9 | Quick Ratio | 0.51 | EPS Q/Q | -31.44% | Profit Margin | 4.52% | RSI (14) | 42.19 | Recom | 2.24 |
| Dividend Gr. 3/5Y | 6.13% 5.65% | Current Ratio | 0.87 | Sales Q/Q | -9.55% | SMA20 | -5% ($185.71) | Beta | 0.22 | Target Price | $193 |
| Payout | 71.53% | Debt/Eq | 0.69 | Earnings | 2026/8/6 | SMA50 | 2.89% ($171.46) | Rel Volume | 0.8 | Prev Close | $179.8 |
| Employees | 72000 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 2.82% 1.96% | SMA200 | 10.12% ($160.21) | Avg Volume(3M) | 2.10M | Price | $176.42 |
| IPO | 1963/9/25 | Option/Short | Yes/Yes | Trades | 22031 | Volume | 1,671,779 | Change | -1.88% |
Company
BDX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💉 This is a US-based large-cap medical device company that supplies medical syringes, diagnostic equipment, and life science instruments. Founded in 1897 and headquartered in New Jersey, it holds a globally leading position in drug delivery, specimen collection, and clinical diagnostics, and is a healthcare stock with a steady track record of dividend increases.
Over the past 1 year, roughly in the middle
9% below its 1-year high.
BDX has weak earning power
14.54% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.0% this year.
Tap to view numbers
The price looks about right
Trading at 53.2 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -15.8% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 2.26% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 99.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IHI 0.05%
USFE 0.03%
LBAY 0.03%
MDPL 0.03%
EQTY 0.03%It ranks #2 in the industry
Based on market cap of $48B.
BDX $48B PER 53.2
ISRG $127B PER 41.3
MDLN $43B PER 38.0
ALC $32B PER 51.0
FAQ
What kind of company is BDX?
BDX belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of BDX?
The market cap of BDX is approximately $48.1B, ranking 331 within its sector.
Does BDX pay dividends?
BDX has a dividend yield of approximately 2.26%, with an annual dividend of $3.99.
What is the P/E ratio of BDX?
BDX has a P/E ratio of approximately 53.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for BDX?
BDX has recorded a 52-week high of $193.07 and a low of $127.54.
